247 related articles for article (PubMed ID: 7541452)
1. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
Tirelli U; Errante D; Dolcetti R; Gloghini A; Serraino D; Vaccher E; Franceschi S; Boiocchi M; Carbone A
J Clin Oncol; 1995 Jul; 13(7):1758-67. PubMed ID: 7541452
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
Lévy R; Colonna P; Tourani JM; Gastaut JA; Brice P; Raphaël M; Taillan B; Andrieu JM
Leuk Lymphoma; 1995 Feb; 16(5-6):451-6. PubMed ID: 7540459
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.
Errante D; Gabarre J; Ridolfo AL; Rossi G; Nosari AM; Gisselbrecht C; Kerneis Y; Mazzetti F; Vaccher E; Talamini R; Carbone A; Tirelli U
Ann Oncol; 1999 Feb; 10(2):189-95. PubMed ID: 10093688
[TBL] [Abstract][Full Text] [Related]
4. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT).
Errante D; Tirelli U; Gastaldi R; Milo D; Nosari AM; Rossi G; Fiorentini G; Carbone A; Vaccher E; Monfardini S
Cancer; 1994 Jan; 73(2):437-44. PubMed ID: 7507401
[TBL] [Abstract][Full Text] [Related]
5. Synchronous presentation of Epstein-Barr virus-associated Hodgkin's disease and adult T-cell leukemia/lymphoma (ATLL) in a patient from an endemic area of ATLL.
Hayashi T; Yamabe H; Haga H; Akasaka T; Kadowaki N; Ohno H; Okuma M; Fukuhara S
Int J Hematol; 1995 Jun; 61(4):215-22. PubMed ID: 8547610
[TBL] [Abstract][Full Text] [Related]
6. A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie controlled clinical trial.
Somers R; Carde P; Henry-Amar M; Tarayre M; Thomas J; Hagenbeek A; Monconduit M; de Pauw BE; Breed WP; Verdonck L
J Clin Oncol; 1994 Feb; 12(2):279-87. PubMed ID: 7509381
[TBL] [Abstract][Full Text] [Related]
7. HIV-related Hodgkin's disease. Report of nine cases.
Novati S; Malfitano A; Sacchi P; Patruno SF; Tornari PM; Rondanelli EG
Haematologica; 1993; 78(1):34-7. PubMed ID: 7684010
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin's disease.
Dolcetti R; Zancai P; De Re V; Gloghini A; Bigoni B; Pivetta B; De Vita S; Carbone A; Boiocchi M
Blood; 1997 Mar; 89(5):1723-31. PubMed ID: 9057656
[TBL] [Abstract][Full Text] [Related]
9. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Chisesi T; Bellei M; Luminari S; Montanini A; Marcheselli L; Levis A; Gobbi P; Vitolo U; Stelitano C; Pavone V; Merli F; Liberati M; Baldini L; Bordonaro R; Pesce EA; Federico M
J Clin Oncol; 2011 Nov; 29(32):4227-33. PubMed ID: 21990405
[TBL] [Abstract][Full Text] [Related]
11. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Gobbi PG; Pieresca C; Federico M; Di Renzo N; Narni F; Iannitto E; Grignani G; Cavanna L; Avanzini P; Partesotti G
J Clin Oncol; 1993 Apr; 11(4):712-9. PubMed ID: 7683044
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
Monfardini S; Tirelli U; Vaccher E; Foà R; Gavosto F
Ann Oncol; 1991 Feb; 2 Suppl 2():201-5. PubMed ID: 1710920
[TBL] [Abstract][Full Text] [Related]
13. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
[TBL] [Abstract][Full Text] [Related]
15. Hodgkin lymphoma among patients infected with HIV in post-HAART era.
Tanaka PY; Pessoa VP; Pracchia LF; Buccheri V; Chamone DA; Calore EE
Clin Lymphoma Myeloma; 2007 Mar; 7(5):364-8. PubMed ID: 17562247
[TBL] [Abstract][Full Text] [Related]
16. Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
Hentrich M; Berger M; Wyen C; Siehl J; Rockstroh JK; Müller M; Fätkenheuer G; Seidel E; Nickelsen M; Wolf T; Rieke A; Schürmann D; Schmidmaier R; Planker M; Alt J; Mosthaf F; Engert A; Arasteh K; Hoffmann C
J Clin Oncol; 2012 Nov; 30(33):4117-23. PubMed ID: 23045592
[TBL] [Abstract][Full Text] [Related]
17. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease.
Murray PG; Billingham LJ; Hassan HT; Flavell JR; Nelson PN; Scott K; Reynolds G; Constandinou CM; Kerr DJ; Devey EC; Crocker J; Young LS
Blood; 1999 Jul; 94(2):442-7. PubMed ID: 10397711
[TBL] [Abstract][Full Text] [Related]
18. Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
Prosnitz LR; Farber LR; Kapp DS; Scott J; Bertino JR; Fischer JJ; Cadman EC
J Clin Oncol; 1988 Apr; 6(4):603-12. PubMed ID: 2451712
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
[TBL] [Abstract][Full Text] [Related]
20. Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
Longo DL; Glatstein E; Duffey PL; Young RC; Ihde DC; Bastian AW; Wilson WH; Wittes RE; Jaffe ES; Hubbard SM; DeVita VT
J Clin Oncol; 1997 Nov; 15(11):3338-46. PubMed ID: 9363863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
